Contact
Julie Di Martino, Ph.D., moved to Bordeaux, France, to receive her college education before moving to New York City in 2016, shortly after graduating, to complete a postdoctoral training at the Icahn School of Medicine at Mount Sinai Hospital, New York, focusing on the role of the extracellular matrix in cancer dormancy.
In 2020, Dr. Di Martino was awarded an Early Career Investigator Award from the METAvivor Foundation supporting breast cancer research to investigate the effect of ACE inhibitors on dormant cancer cells. Most recently, she was awarded the 2022 Rupert Timpl Award from the International Society for Matrix Biology in recognition of her postdoctoral work, recently published in Nature Cancer.
Dr. Di Martino has published in respected peer-reviewed journals such as the Journal of Cell Biology, Cancer Discovery, Nature, Nature Cancer, and Cell. Dr. Di Martino has trained numerous students in the last decade, providing strong support and mentoring, and is committed to training and mentoring NYMC students from all levels. At NYMC, her research focuses on dormancy escape and cancer metastasis using a combination of in vivo models and imaging technics.
Education
- Ph.D., Health and Life Sciences, Cellular Biology and Physiopathology, University of Bordeaux
- M.S., Cellular and Molecular Genetics, University of Bordeaux
Honors and Awards
- NYMC Outstanding Faculty Award, 2024
- Rupert Timpl awardee, International Society for Matrix Biology, 2022
Publications
- Al Azim M, Di Martino JS. "ECM, integrins, and DDRs: A nexus of cancer progression, therapy, and future directions." Matrix biology : journal of the International Society for Matrix Biology, 138(), (2025) 27-43. doi: 10.1016/j.matbio.2025.04.002
- Fard SS, Kundu N, Torres AS, et. al. "Inhibition of NAMPT as a therapeutic strategy to suppress tumor growth in lymphangioleiomyomatosis." Biochimica et biophysica acta. Molecular cell research, 1872(6), (2025) 119986. doi: 10.1016/j.bbamcr.2025.119986
- Mondal C, Gacha-Garay MJ, Larkin KA, et. al. "A proliferative to invasive switch is mediated by srGAP1 downregulation through the activation of TGF-β2 signaling." Cell reports, 40(12), (2022) 111358. doi: 10.1016/j.celrep.2022.111358
- Di Martino JS, Nobre AR, Mondal C, et. al. "A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy." Nature cancer, 3(1), (2022) 90-107. doi: 10.1038/s43018-021-00291-9
- Nobre AR, Risson E, Singh DK, et. al. "Bone marrow NG2(+)/Nestin(+) mesenchymal stem cells drive DTC dormancy via TGFβ2." Nature cancer, 2(3), (2021) 327-339. doi: 10.1038/s43018-021-00179-8
- Di Martino JS, Akhter T, Bravo-Cordero JJ, et. al. "Remodeling the ECM: Implications for Metastasis and Tumor Dormancy." Cancers, 13(19), (2021) . doi: 10.3390/cancers13194916
- Mondal C, Di Martino JS, Bravo-Cordero JJ, et. al. "Actin dynamics during tumor cell dissemination." International review of cell and molecular biology, 360(), (2021) 65-98. doi: 10.1016/bs.ircmb.2020.09.004
